Contemporary View on the Meloxicam Treatment of Rheumatic Diseases

Czech version

Authors: D. Suchý; H. Brabcová
Authors‘ workplace: Oddělení klinické farmakologie FN, Plzeň, přednosta doc. MUDr. O. Mayer, CSc.
Published in: Prakt. Lék. 2003; (8): 457-460
Category:

Overview

Contemporary View on the Meloxicam Treatment of Rheumatic DiseasesNonsteroidal antiinflamatory drugs represent one of widely used group of drugs. Meloxicam isrelatively new non steroidal antiinflamatory drug approved for the treatment of rheumaticdiseases. Meloxicam has been shown to be COX-2 preferential, particularly at lowest therapeuticdoses. In clinical trials of meloxicam in osteoarthritis and rheumatoid arthritis it was foundto be as effective as piroxicam, diclofenac and naproxen with less gastrointestinal symptomsand less perforations, obstructions and bleedings.

Key words:
nonsteroidal antiinflamatory drugs - rheumatic diseases - meloxicam - treatment.

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.